CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 195 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,653 | +1241.6% | 318,027 | +996.5% | 0.04% | +1100.0% |
| Q2 2023 | $645 | +216.2% | 29,004 | +207.5% | 0.00% | +200.0% |
| Q1 2023 | $204 | +6.8% | 9,432 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $191 | -100.0% | 9,432 | -69.4% | 0.00% | -75.0% |
| Q3 2022 | $790,000 | +7.8% | 30,813 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $733,000 | +2.4% | 30,813 | -3.2% | 0.00% | +33.3% |
| Q1 2022 | $716,000 | +17.4% | 31,845 | +3.3% | 0.00% | +50.0% |
| Q4 2021 | $610,000 | +15.1% | 30,813 | +14.3% | 0.00% | 0.0% |
| Q3 2021 | $530,000 | -0.9% | 26,964 | +10.8% | 0.00% | 0.0% |
| Q2 2021 | $535,000 | +17.8% | 24,336 | +27.4% | 0.00% | 0.0% |
| Q1 2021 | $454,000 | -84.8% | 19,103 | -83.3% | 0.00% | -83.3% |
| Q4 2020 | $2,992,000 | +16.1% | 114,384 | -22.7% | 0.01% | +9.1% |
| Q3 2020 | $2,576,000 | -52.5% | 148,046 | -54.1% | 0.01% | -52.2% |
| Q2 2020 | $5,424,000 | +29.8% | 322,524 | -8.2% | 0.02% | -4.2% |
| Q1 2020 | $4,180,000 | +98.5% | 351,272 | +101.8% | 0.02% | +140.0% |
| Q4 2019 | $2,106,000 | -28.4% | 174,034 | -16.3% | 0.01% | -23.1% |
| Q3 2019 | $2,941,000 | -5.3% | 208,039 | -25.3% | 0.01% | -13.3% |
| Q2 2019 | $3,107,000 | -35.8% | 278,600 | -32.4% | 0.02% | -28.6% |
| Q1 2019 | $4,837,000 | +75.6% | 411,843 | +99.7% | 0.02% | +50.0% |
| Q4 2018 | $2,755,000 | -86.2% | 206,276 | -85.5% | 0.01% | -83.1% |
| Q3 2018 | $20,000,000 | -54.3% | 1,426,499 | -48.8% | 0.08% | -56.1% |
| Q2 2018 | $43,800,000 | -19.7% | 2,786,241 | -15.9% | 0.19% | -19.9% |
| Q1 2018 | $54,522,000 | +21.7% | 3,314,569 | +33.6% | 0.24% | +21.6% |
| Q4 2017 | $44,803,000 | +1.1% | 2,480,848 | +8.1% | 0.19% | -1.0% |
| Q3 2017 | $44,299,000 | +121.0% | 2,295,394 | +35.1% | 0.20% | +115.4% |
| Q2 2017 | $20,049,000 | +64.7% | 1,698,971 | +53.0% | 0.09% | +62.5% |
| Q1 2017 | $12,170,000 | +361.2% | 1,110,509 | +205.5% | 0.06% | +330.8% |
| Q4 2016 | $2,639,000 | +117.2% | 363,449 | +94.5% | 0.01% | +116.7% |
| Q3 2016 | $1,215,000 | +631.9% | 186,866 | +513.9% | 0.01% | +500.0% |
| Q2 2016 | $166,000 | -42.8% | 30,440 | -50.7% | 0.00% | 0.0% |
| Q1 2016 | $290,000 | -42.7% | 61,761 | -39.2% | 0.00% | -66.7% |
| Q4 2015 | $506,000 | -36.4% | 101,636 | -52.0% | 0.00% | -25.0% |
| Q3 2015 | $796,000 | +177.4% | 211,686 | +343.1% | 0.00% | +300.0% |
| Q2 2015 | $287,000 | – | 47,773 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 6,911,376 | $155,644,000 | 6.95% |
| Parallel Advisors, LLC | 1,944,319 | $47,014,000 | 1.86% |
| TANAKA CAPITAL MANAGEMENT INC | 39,289 | $885,000 | 1.79% |
| S&T BANK/PA | 508,546 | $11,452,000 | 1.73% |
| Bridge City Capital, LLC | 83,967 | $1,891,000 | 0.88% |
| Birchview Capital, LP | 50,000 | $1,126,000 | 0.81% |
| Quantedge Capital Pte Ltd | 113,012 | $2,545,000 | 0.75% |
| FAS Wealth Partners, Inc. | 289,625 | $6,522,000 | 0.61% |
| AJ WEALTH STRATEGIES, LLC | 396,029 | $8,919,000 | 0.44% |
| TRUSTCORE FINANCIAL SERVICES, LLC | 208,806 | $4,702,000 | 0.41% |